Vitamin D deficiency - Prognostic marker or mortality risk factor in end stage renal disease patients with diabetes mellitus treated with hemodialysis - A prospective multicenter study

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Schiller, Adalbert ^a   Gadalean, Florica ^a   Schiller, Oana ^b   Timar, Romulus ^a   Bob, Flaviu ^a   Munteanu, Mircea ^a   Stoian, Dana ^a   Mihaescu, Adelina ^a   Timar, Bogdan ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b B Braun Avitum Dialysis Center Timisoara   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; PARATHYROID HORMONE; VITAMIN D;

ADULT; AGE; ARTICLE; BODY MASS; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; MORTALITY; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TREATMENT DURATION; VITAMIN D DEFICIENCY; AGED; BLOOD; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPLICATION; MULTICENTER STUDY; PATHOLOGY;

ADULT; AGED; DIABETES MELLITUS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; RENAL DIALYSIS; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84930679103     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126586     Document Type: Article

References (58)

1. Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Ishani A, et al. US Renal Data System 2013 Annual Data Report. Am J Kidney Dis. 2014; 63(1 Suppl):A7. doi: 10.1053/j.ajkd.2013.11.001 PMID: 24360288
2. Hill CJ, Fogarty DG. Changing trends in end-stage renal disease due to diabetes in the United Kingdom. J Ren Care. 2012; 38 Suppl 1:12-22 doi: 10.1111/j.1755-6686.2012.00273.x PMID: 22348360
3. Levin A, Li YC. Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease? Kidney Int. 2005; 68(5):1973-81. PMID: 16221197
4. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int. 2000; 58(1):353-62. PMID: 10886582
5. Sarnak MJ, Coronado BE, Greene T, Wang SR, Kusek JW, Beck GJ, et al. Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol. 2002; 57(5):327-35. PMID: 12036190
6. Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int. 2009; 75(1):88-95 doi: 10.1038/ki.2008.501 PMID: 18843258
7. Wang L, Song Y, Manson JE, Pilz S, März W, Michaëlsson K, et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012; 5:819-29. doi: 10.1161/CIRCOUTCOMES.112.967604 PMID: 23149428
8. Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr. 2012; 95:91-100. doi: 10.3945/ajcn.111.014779 PMID: 22170374
9. Fraser A, Williams D, Lawlor DA. Associations of serum 25-hydroxyvitamin D, parathyroid hormone and calcium with cardiovascular risk factors: analysis of 3 NHANES cycles (2001-2006). PLoS One. 2010; 5(11):e13882 doi: 10.1371/journal.pone.0013882 PMID: 21085485
10. Krassilnikova M, Ostrow K, Bader A, Heeger P, Mehrotra A. Low Dietary Intake of Vitamin D and Vitamin D Deficiency in Hemodialysis Patients. J Nephrol Ther. 2014; 4(3). PMID: 25254144
11. London GM, Guérin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol. 2007; 18:613-20. PMID: 17202417
12. Matias PJ, Ferreira C, Jorge C, Borges M, Aires I, Amaral T, et al. 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients. Nephrol Dial Transplant. 2009; 24:611-8 doi: 10.1093/ndt/gfn502 PMID: 18775809
13. Drechsler C, Pilz S, Obermayer-Pietsch B, Verduijn M, Tomaschitz A, Krane V, et al. Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur Heart J. 2010; 31:2253-61. doi: 10.1093/eurheartj/ehq246 PMID: 20688781
14. Bucharles S, Barberato SH, Stinghen AE, Gruber B, Meister H, Mehl A, et al. Hypovitaminosis D is associated with systemic inflammation and concentric myocardial geometric pattern in hemodialysis patients with low iPTH levels. Nephron Clin Pract. 2011; 118:c384-91. doi: 10.1159/000323664 PMID: 21325871
15. Mehrotra R, Kermah D, Budoff M, Salusky IB, Mao SS, Gao YL, et al Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol. 2008; 3:1144-51. doi: 10.2215/CJN.05781207 PMID: 18417740
16. Ureña-Torres P, Metzger M, Haymann JP, Karras A, Boffa JJ, Flamant M, et al. Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD. Am J Kidney Dis. 2011; 58:544-53 doi: 10.1053/j.ajkd.2011.04.029 PMID: 21803465
17. Joergensen C, Gall MA, Schmedes A, Tarnow L, Parving HH, Rossing P. Vitamin D Levels and Mortality in Type 2 Diabetes Diabetes Care. 2010; 33: 2238-2243. doi: 10.2337/dc10-0582 PMID: 20606205
18. Joergensen C, Hovind P, Schmedes A, Parving HH, Rossing P. Vitamin D levels, microvascular complications, and mortality in type 1 diabetes. Diabetes Care. 2011; 34:1081-5 doi: 10.2337/dc10-2459 PMID: 21525501
19. IOM (Institute of Medicine). 2011. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press
20. Schöttker B, Haug U, Schomburg L, Köhrle J, Perna L, Müller H, et al. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr. 2013; 97(4):782-93. doi: 10.3945/ajcn.112.047712 PMID: 23446902
21. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7):1911-30. doi: 10.1210/jc.2011-0385 PMID: 21646368
22. Brun E, Nelson RG, Bennett PH, Imperatore G, Zoppini G, Verlato G, et al. Diabetes duration and cause-specific mortality in the Verona Diabetes Study. Diabetes Care. 2000; 23(8):1119-23. PMID: 10937508
23. Fernández-Martín JL, Carrero JJ, Benedik M, Bos WJ, Covic A, Ferreira A, et al. COSMOS: the dialysis scenario of CKD-MBD in Europe. Nephrol Dial Transplant. 2013; 28:1922-35 doi: 10.1093/ndt/gfs418 PMID: 23166310
24. ERA-EDTA Registry: ERA-EDTA Registry Annual Report 2012. Academic Medical Center, Department of Medical Informatics, Amsterdam, The Netherlands, 2014; ISBN 817480-4-9
25. Hayashino Y, Fukuhara S, Akiba T, Akizawa T, Asano Y, Saito A, et al. Diabetes, glycaemic control and mortality risk in patients on haemodialysis: the Japan Dialysis Outcomes and Practice Pattern Study. Diabetologia. 2007; 50:1170-7. PMID: 17393134
26. Sattar A, Argyropoulos C, Weissfeld L, Younas N, Fried L, Kellum JA, et al. All-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients. BMC Nephrol. 2012;1; 13:130. doi: 10.1186/1471-2369-13-130 PMID: 23025844
27. Schroijen MA, Dekkers OM, Grootendorst DC, Noordzij M, Romijn JA, Kredier RT, et al. Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition. BMC Nephrol. 2011; 9; 12:69 doi: 10.1186/1471-2369-12-69 PMID: 22182634
28. Ozener C, Arikan H, Karayaylali I, Utas C, Bozfakioglu S, Akpolat T, et al. The impact of diabetes mellitus on peritoneal dialysis: the Turkey Multicenter Clinic Study. Ren Fail. 2014; 36:149-53 doi: 10.3109/0886022X.2013.843275 PMID: 24131086
29. Afkarian M, Sachs MC, Kestenbaum B, Hirsch IB, Tuttle KR, Himmelfarb J, et al. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol. 2013; 24:302-8. doi: 10.1681/ASN.2012070718 PMID: 23362314
30. Echida Y, Mochizuki T, Uchida K, Tsuchiya K, Nitta K. Risk factors for vitamin D deficiency in patients with chronic kidney disease. Intern Med. 2012; 51:845-50 PMID: 22504237
31. Drechsler C, Verduijn M, Pilz S, Dekker FW, Krediet RT, Ritz E, et al. Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant. 2011; 26(3):1024-32. doi: 10.1093/ndt/gfq606 PMID: 20947538
32. Jean G, Lataillade D, Genet L, Legrand E, Kuentz F, Moreau-Gaudry X, et al. Impact of hypovitaminosis D and alfacalcidol therapy on survival of hemodialysis patients: results from the French ARNOS study. Nephron Clin Pract. 2011; 118:c204-10 doi: 10.1159/000321507 PMID: 21178377
33. Alshayeb HM, Wall BM, Showkat A, Mangold T, Quarles LD. Chronic kidney disease and diabetes mellitus predict resistance to vitamin D replacement therapy. Am J Med Sci. 2013; PubMed PMID: 23221508
34. Anand S, Kaysen GA, Chertow GM, Johansen KL, Grimes B, Dalrymple LS, et al. Vitamin D deficiency, self-reported physical activity and health-related quality of life: the Comprehensive Dialysis Study. Nephrol Dial Transplant. 2011; 26:3683-8. doi: 10.1093/ndt/gfr098 PMID: 21430182
35. Del Valle E, Negri AL, Aguirre C, Fradinger E, Zanchetta JR. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis. Hemodial Int. 2007; 11(3):315-21. PMID: 17576296
36. Bansal B, Bansal S, Mithal A, Kher V, Marwaha R. Vitamin D deficiency in hemodialysis patients. Indian J Endocrinol Metab. 2012; 16(2):270-3. doi: 10.4103/2230-8210.93749 PMID: 22470866
37. Barreto DV, Barreto FC, Liabeuf S, Temmar M, Boitte F, Choukroun G, et al. Vitamin D affects survival independently of vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol. 2009; 4 (6):1128-35. doi: 10.2215/CJN.00260109 PMID: 19443628
38. Bhan I, Burnett-Bowie SA, Ye J, Tonelli M, Thadhani R. Clinical measures identify vitamin D deficiency in dialysis. Clin J Am Soc Nephrol. 2010; 5:460-7 doi: 10.2215/CJN.06440909 PMID: 20185603
39. Schöttker B, Jorde R, Peasey A, Thorand B, Jansen EH, Groot Ld et al. Vitamin D and mortality: metaanalysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ. 2014; 348: g3656. doi: 10.1136/bmj.g3656 PMID: 24938302
40. Sempos CT, Durazo-Arvizu RA, Dawson-Hughes B, Yetley EA, Looker AC, Schleicher RL, et al. Is there a reverse J-shaped association between 25-hydroxyvitamin D and all-cause mortality? Results from the U.S. nationally representative NHANES. J Clin Endocrinol Metab. 2013; 98:3001-9 doi: 10. 1210/jc.2013-1333 PMID: 23666975
41. Mehrotra R, Kermah DA, Salusky IB, Wolf MS, Thadhani RI, Chiu YW, et al. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int. 2009; 76:977-83 doi: 10.1038/ki. 2009.288 PMID: 19657329
42. Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S. Vitamin D status and mortality risk in CKD: a metaanalysis of prospective studies. Am J Kidney Dis. 2011; 58:374-82. doi: 10.1053/j.ajkd.2011.03.020 PMID: 21636193
43. Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomized intervention studies. BMJ. 2014;1; 348:g1903. doi: 10.1136/bmj.g1903 PMID: 24690623
44. Zheng Z, Shi H, Jia J, Li D, Lin S. Vitamin D supplementation and mortality risk in chronic kidney disease: a meta-analysis of 20 observational studies. BMC Nephrol. 2013; 14:199. doi: 10.1186/1471- 2369-14-199 PMID: 24066946
45. de Boer IH, Thadhani R. Vitamin D deficiency: consequence or cause of CKD? Clin J Am Soc Nephrol. 2013; 8:1844-6. doi: 10.2215/CJN.09480913 PMID: 24135217
46. Balden R, Selvamani A, Sohrabji F. Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats. Endocrinology. 2012; 153:2420-35. doi: 10. 1210/en.2011-1783 PMID: 22408173
47. Lang CL, Wang MH, Chiang CK, Lu KC. Vitamin D and the Immune System from the Nephrologist's Viewpoint. ISRN Endocrinol. 2014; 2014:1054-56.
48. Achinger SG, Ayus JC. The role of vitamin D in left ventricular hypertrophy and cardiac function. Kidney Int Suppl. 2005;(95:) :S37-42. PMID: 15882312
49. Li YC. Vitamin D in chronic kidney disease. Contrib Nephrol. 2013; 180:98-109 doi: 10.1159/000346789 PMID: 23652553
50. Canale D, de Bragança AC, Gonçalves JG, Shimizu MH, Sanches TR, Andrade L et al. Vitamin D Deficiency Aggravates Nephrotoxicity, Hypertension and Dyslipidemia Caused by Tenofovir: Role of Oxidative Stress and Renin-Angiotensin System PLoS One. 2014; 9(7): e103055. doi: 10.1371/journal.pone.0103055 PMID: 25048368
51. Al Mheid I, Patel R, Murrow J, Morris A, Rahman A, Fike L, et al. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol. 2011; 58:186-92. doi: 10.1016/j.jacc.2011.02.051 PMID: 21718915
52. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, et al Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008; 29:726-76 doi: 10.1210/er.2008-0004 PMID: 18694980
53. Folsom AR, Alonso A, Misialek JR, Michos ED, Selvin E, Coresh J, et al. Parathyroid hormone concentration and risk of cardiovascular diseases: The Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2014; 168:296-302. doi: 10.1016/j.ahj.2014.04.017 PMID: 25173540
54. Wahl P, Xie H, Scialla J, Anderson CA, Bellovich K, Brecklin C, et al. Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease. Diabetes Care. 2012; 35:994-1001. doi: 10.2337/dc11-2235 PMID: 22446176
55. Dan S, Aditya P, Samanta M, Jothimalar R, Soundarajan P. Effect of glycemic control on intact parathyroid hormone level in end stage renal disease patients on maintenance hemodialysis. Diabetes Res Clin Pract. 2014. pii:S0168-8227(14)00180-6. doi: 10.1016/j.diabres.2014.04.002
56. Murakami R, Murakami S, Tsushima R, Ueda C, Mikami K, Ebina T, et al. Glycaemic control and serum intact parathyroid hormone levels in diabetic patients on haemodialysis therapy. Nephrol Dial Transplant.2008; 23:315-20 PMID: 17956892
57. Levin GP, Robinson-Cohen C, de Boer IH, Houston DK, Lohman K, Liu Y et al. Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAMA. 2012 Nov 14; 308:1898-905. doi: 10.1001/jama.2012.17304 PMID: 23150009
58. Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2014; 2:76-89 doi: 10.1016/S2213-8587(13)70165-7 PMID: 24622671